Allogeneic stem cell-based transplants may be limited by allograft rejection, as is seen with conventional organ transplantation. One way to avert such a response is to use autologous stem cells, but that may carry the risk of recurrence of the original disease, particularly in the context of a gene
Supported phospholipid bilayers as a platform for neural progenitor cell culture
✍ Scribed by D. Thid; K. Holm; P.S. Eriksson; J. Ekeroth; B. Kasemo; J. Gold
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 584 KB
- Volume
- 84A
- Category
- Article
- ISSN
- 1549-3296
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Supported phospholipid bilayers constitute a biomimetic platform for cell behavior studies and a new approach to the design of cell culture substrates. Phosphocholine bilayers are resistant to cell attachment, but can be functionalized with bioactive molecules to promote specific cell interactions. Here, we explore phosphocholine bilayers, functionalized with the laminin‐derived IKVAV pentamer, as substrates for attachment, growth, and differentiation of neural progenitor cells (AHPs). By varying peptide concentration (0–10%), we discovered a strongly nonlinear relationship between cell attachment and IKVAV concentration, with a threshold of 1% IKVAV required for attachment, and saturation in cell binding at 3% IKVAV. This behavior, together with the 10‐fold reduction in cell attachment when using a jumbled peptide sequence, gives evidence for a specific interaction between IKVAV and its AHP cell‐surface receptor. After 8 days in culture, the peptide‐functionalized bilayers promoted a high degree of cell cluster formation. This is in contrast to the predominant monolayer growth, observed for these cells on the standard laminin coated growth substrates. The peptide‐functionalized bilayer did not induce differentiation levels over those observed for the laminin coated substrates. These results are promising in that peptide‐functionalized bilayers can allow attachment and growth of stem cells without induction of differentiation. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
📜 SIMILAR VOLUMES
## Abstract It is expected that human neural stem/progenitor cells (hNS/PCs) will some day be used in cell replacement therapies. However, their availability is limited because of ethical issues, so they have to be expanded to obtain sufficient amounts for clinical application. Moreover, in‐vitro‐m